Skip to main content
OpenTrials
Completed

NCT Number: NCT02073162

REstrictive Versus LIbEral Fluid Therapy in Major Abdominal Surgery

Physicians differ in their approaches to surgical fluid therapy, with some preferring higher volumes and others lower volumes. Each approach has potential advantages and disadvantages. Currently, there is no compelling evidence that one approach is better than the other. This study tests whether giving a volume on the low end of the usual amount ("restrictive management") has a different rate of complications compared to a volume on the high end of the usual amount ("liberal management"). This study will compare liberal and restrictive fluid management to determine their effects on major complications after abdominal surgery.

Those who take part in the study will be visited five times before and after surgery in the hospital. Once discharged from the hospital, participants will be called 4 times on the telephone.

Preadmission Clinic/Preoperative Visit

* Sign the consent document * Have blood drawn for standard preoperative tests (standard of care) * Have an electrocardiogram (standard of care) * Complete a questionnaire on disability (research)

Day of Surgery

* Have blood drawn if not already done during the first visit (standard of care) * Have an electrocardiogram if not already done during the first visit (standard of care) * Be randomly assigned to either restrictive or liberal fluid management (research)

Post-op Day 1

* Have an electrocardiogram done (research) * Have blood drawn for standard tests (standard of care) * Have a wound inspection, if there is a change of dressing (standard of care) * Complete a questionnaire about your recovery (research)

Post-op Day 3

* Have blood drawn for standard tests (standard of care) and c-reactive protein, which can indicate infection (for research). * Have a wound inspection, if there is a change of dressing (standard of care) * Complete a questionnaire about your recovery (research)

Day of Discharge

* Have a wound inspection, if there is a change of dressing (standard of care)

30-Day Follow-up Phone Call * Complete a questionnaire about your recovery (research) * Complete a questionnaire about disability (research)

3 Month, 6-Month, and 12-Month Follow-up Phone Calls * Complete a questionnaire about disability (research)

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adults (≥18 years) undergoing elective major surgery and providing informed consent
  • all types of open or lap-assisted abdominal or pelvic surgery with an expected duration of at least 2 hours, and an expected hospital stay of at least 3 days (for example, oesophagectomy, gastrectomy, pancreatectomy, colectomy, aortic or aorto-femoral vascular surgery, nephrectomy, cystectomy, open prostatectomy, radical hysterectomy, and abdominal incisional hernia repair)
  • at increased risk of postoperative complications, defined as at least one of the following criteria:
  • age ≥70 years
  • known or documented history of coronary artery disease
  • known or documented history of heart failure
  • diabetes currently treated with an oral hypoglycaemic agent and/or insulin
  • preoperative serum creatinine >200 μmol/L (>2.8 mg/dl)
  • morbid obesity (BMI ≥35 kg/m2)
  • preoperative serum albumin <30 g/L
  • anaerobic threshold (if done) <12 mL/kg/min
  • or two or more of the following risk factors:
  • ASA 3 or 4
  • chronic respiratory disease
  • obesity (BMI 30-35 kg/m2)
  • aortic or peripheral vascular disease
  • preoperative haemoglobin <100 g/L
  • preoperative serum creatinine 150-199 μmol/L (>1.7 mg/dl)
  • anaerobic threshold (if done) 12-14 mL/kg/min

Exclusion criteria

  • urgent or time-critical surgery
  • ASA physical status 5 - such patients are not expected to survive with or without surgery, and their underlying illness is expected to have an overwhelming effect on outcome (irrespective of fluid therapy)
  • chronic renal failure requiring dialysis
  • pulmonary or cardiac surgery - different pathophysiology, and thoracic surgery typically have strict fluid restrictions
  • liver resection - most units have strict fluid/CVP limits in place and won't allow randomisation
  • minor or intermediate surgery, such as laparoscopic cholecystectomy, transurethral resection of the prostate, inguinal hernia repair, splenectomy, closure of colostomy - each of these are typically "minor" surgery with minimal IV fluid requirements, generally low rates of complications and mostly very good survival.

Treatment and study plan

Major abdominal Surgery

Procedure

•All types of open or lap-assisted abdominal or pelvic surgery with an expected duration of at least 2 hours, and an expected hospital stay of at least 3 days (for example, oesophagectomy, gastrectomy, pancreatectomy, colectomy, aortic or aorto-femoral vascular surgery, nephrectomy, cystectomy, open prostatectomy, radical hysterectomy, and abdominal incisional hernia repair)

Primary outcomes

  1. Number of Participants With Disability-free Survival

    Time frame: 1 year

    Disability was defined as a persistent impairment in health status (lasting ≥6 months), as measured by a score of at least 24 points on the WHODAS questionnaire, which reflects a disability level of at least 25% (the threshold point between "disabled" and "not disabled").

Secondary outcomes

  1. Number of Participants With Acute Kidney Injury

    Time frame: 90 days

  2. Number of Participants With a Composite of Mortality or Major Septic Complications

    Time frame: 30-day

  3. Number of Participants With Surgical-site Infection

    Time frame: Indexed hospital stay

  4. Number of Participants With Sepsis

    Time frame: Indexed hospital stay

  5. Number of Participants With Anastomotic Leak

    Time frame: Indexed hospital stay

  6. Number of Participants With Pneumonia

    Time frame: Indexed hospital stay

  7. Number of Participants Undergoing Renal-replacement Therapy

    Time frame: Indexed hospital stay

  8. Number of Participants With Pulmonary Edema

    Time frame: Indexed hospital stay

  9. Number of Participants With Unplanned Admission to ICU

    Time frame: 30 day

  10. Death

    Time frame: 90 days

  11. Death

    Time frame: 12 month

Sponsors and collaborators

Lead sponsor

The Cleveland Clinic

Other

Registry information

Important dates

Study start
2014
Primary completion
2016
Study completion
2018
First posted
Feb 27, 2014
Registry last updated
Oct 31, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.